An Unusual Presentation of ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report
DOI:
https://doi.org/10.21276/apalm.3765Keywords:
lymphoma, t-cell, large-cell, anaplasticAbstract
Anaplastic large cell lymphoma (ALCL) is a rare but aggressive type of non Hodgkins lymphoma that develop from mature T cells. Case: A 73-year-old male presented with a swelling over the medial aspect of the right leg. An excision biopsy was performed, and histopathological examination revealed a malignant round cell neoplasm. Immunohistochemistry was negative for CD45, CD20, and CD3 showing strong, diffuse CD30 positivity. Based on diffuse CD30 positivity, further immunohistochemical markers, including ALK and additional T-cell markers were done and a diagnosis of ALK-negative ALCL was made.
ALCL can rarely present with the absence of characteristic hallmark cells and negativity for CD45 and some of the T cell markers. CD45 and CD3 negativity can lead to misdiagnosis by omission of further markers. In this case, further lymphoid markers were done due to the diffuse CD30 positivity. Hence, ALK-negative ALCL is a diagnostic challenge. ALCL may rarely lack characteristic hallmark cells and show negativity for CD45 and certain T-cell markers, which can lead to diagnostic pitfalls if additional immunohistochemical workup is not performed. In the present case, diffuse CD30 positivity prompted further lymphoid marker evaluation, leading to the correct diagnosis. This highlights that ALK-negative ALCL remains a diagnostic challenge and highlights the importance of a broad immunohistochemical panel in atypical presentations.
References
1. Lim M, Dave SD, Du MQ. Mature T- cell and NK-cell neoplasms // Anaplastic Large cell lymphoma. In: WHO CLASSIFICATION OF HEMATOLYMPHOID TUMORS- 5TH EDITION, Lyon (France): International Agency for Research in Cancer; 2024. p. 734–736.
2. Kao EY, Mukkamalla SKR, Lynch DT. ALK Negative Anaplastic Large Cell Lymphoma. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
3. Catalina Amador, Andrew L Feldman, How I Diagnose Anaplastic Large Cell Lymphoma, American Journal of Clinical Pathology, Volume 155, Issue 4, April 2021, Pages 479–497
4. Shang Z, Zhang Q, Liu W, Wu J, Zhang Y, Xiao Y. Case Report: A recurrent case of ALK-ALCL after autologous transplantation was successfully treated with BV + a modified CHEP chemotherapy containing mitoxantrone hydrochloride liposome with the addition of chidamide maintenance therapy. Front Oncol. 2023 Oct 2;13:1242552. doi: 10.3389/fonc.2023.1242552. PMID: 37849796; PMCID: PMC10577165.
5. Leventaki V, Bhattacharyya S, Lim MS. Pathology and genetics of anaplastic large cell lymphoma. Semin Diagn Pathol [Internet]. 2020;37(1):57–71. Available from: http://dx.doi.org/10.1053/j.semdp.2019.12.002
6. Seif-Aldin Abdul Rahman, Karam Loutfi, Tareq Turk, Ali Abdul Rahman, Haidara Kherbek, Abdulmoniem Ghanem, Zuheir Alshehabi, A challenging case of ALK-negative anaplastic large cell lymphoma in a 12-year-old boy: A rare case report from Syria,Annals of Medicine and Surgery, Volume 79,2022,https://doi.org/10.1016/j.amsu.2022.104085.
7. Jacobsen, E. (2006). Anaplastic large-cell lymphoma, T-/null-cell type. The Oncologist, 11(7), 831–840. https://doi.org/10.1634/theoncologist.11-7-831
8. Abdallah J, Jabareen M, Alhroub W, Ahmad MS, Risheq Z, Aqel M, Hour H, Halaykh R, Amleh M, Hamoudah I, Janazerah A, Karama A. ALK-Negative Anaplastic Large Cell Lymphoma With Rare Scalp Involvement: A Case Report and Literature Review. J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251388258. doi: 10.1177/23247096251388258. Epub 2025 Nov 11. PMID: 41216891; PMCID: PMC12605880.
9. Bakri, B. R., Baldavira, C. M., Pirani, W. M., Ab’Saber, A., & Capelozzi, V. L. (2025). Anaplastic Large Cell Lymphoma, ALK-Negative: A Rare Case with Histopathological and Immunohistochemical Features. Brazilian Journal of Case Reports, 6(1), bjcr124. https://doi.org/10.52600/2763-583X.bjcr.2026.6.1.bjcr124
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Tinu Francis Chandy, Divya S, C G Geetha, P.K. Mohanan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
How to Cite
